What Causes Low Mood with Endometriosis?

What Causes Low Mood with Endometriosis?

Low mood in endometriosis is real, common, and biologically driven — not a psychological overreaction to a painful condition. Research suggests that 40–86% of people with endometriosis experience clinically significant depressive symptoms, a rate several times higher than the general population. The main caveat: the drivers are multifactorial, so a single intervention rarely resolves it. The exception is the small subset whose mood lifts substantially once surgical lesion removal reduces systemic inflammation.

Why Endometriosis Affects Brain Chemistry

Endometriosis is not just a pelvic condition. It is a systemic inflammatory disease with measurable effects on the central nervous system. Lesions outside the uterus produce and respond to estrogen, secrete inflammatory cytokines — particularly IL-6, IL-1β, and TNF-α — and trigger persistent immune activation that reaches the brain via the vagus nerve and circulating mediators.

Chronic neuroinflammation suppresses neurogenesis in the hippocampus, reduces serotonin transporter expression, and blunts dopamine reward signaling. A 2019 meta-analysis of 21 studies confirmed that women with endometriosis have significantly elevated rates of depression and anxiety compared to controls, with odds ratios ranging from 2.77 to 8.00 depending on the diagnostic criteria used (Culley et al., Human Reproduction Update 2013; PMID: 23644364; and Laganà et al., Biomedicines 2019).

This is not incidental comorbidity — it is a downstream consequence of the same inflammatory and hormonal chaos driving the physical symptoms.

The Estrogen–Serotonin Connection

Estrogen and serotonin are tightly linked. Estrogen upregulates serotonin synthesis, promotes serotonin receptor density, and inhibits monoamine oxidase (MAO) — the enzyme that breaks serotonin down. In healthy hormonal cycling, this relationship supports stable mood during the follicular phase.

In endometriosis, the picture is more complicated. Lesions produce their own estrogen via local aromatase overexpression, creating pockets of hyperestrogenism even when serum estradiol looks normal. At the same time, progesterone resistance — a hallmark of endometriosis — means the calming, GABAergic effects of progesterone's metabolite allopregnanolone are blunted. The result is a neuroendocrine environment that is neither cleanly high-estrogen nor low-estrogen, but dysregulated in ways that destabilize mood circuitry.

Fluctuations in estrogen, rather than absolute levels, are particularly disruptive to serotonin. Rapid drops — common around menstruation and during hormonal treatments — create transient serotonin troughs that manifest as low mood, irritability, and emotional lability. If you've noticed mood changes clustering around your cycle, the hormonal and nutritional root causes of mood swings article explores this pattern in more detail.

Chronic Pain, HPA Axis Dysregulation, and Cortisol

Chronic pain is one of the most potent stressors the hypothalamic-pituitary-adrenal (HPA) axis faces. In endometriosis, persistent pelvic pain, dysmenorrhea, and dyspareunia maintain continuous activation of the stress response. Over months and years, this drives cortisol dysregulation — initially elevated, then blunted or flattened as adrenal output adapts.

Cortisol dysregulation has three direct consequences for mood:

1. Hippocampal atrophy — glucocorticoid excess inhibits BDNF (brain-derived neurotrophic factor) and reduces hippocampal volume, a finding consistently associated with depression.
2. Disrupted diurnal rhythm — flattened cortisol curves impair morning alertness and afternoon energy regulation, producing fatigue-driven low mood that worsens toward evening.
3. Immune dysregulation — cortisol normally dampens inflammatory cytokine production. When this feedback loop breaks down, IL-6 and TNF-α rise further, compounding neuroinflammation.

A 2021 study in the Journal of Pain Research found that endometriosis patients showed measurably altered HPA axis reactivity compared to healthy controls, with blunted cortisol awakening response correlating with greater depressive symptom burden (Sieberg et al., 2020; PMID: 33204151).

This is why many people with endometriosis describe their low mood as less like classic sadness and more like a heavy, motivationless flatness — the signature of HPA exhaustion rather than acute grief.

Nutrient Depletion: The Overlooked Driver

Endometriosis creates substantial nutrient demands that are rarely addressed in standard gynecological care. Three depletions are particularly relevant to mood:

Iron

Menorrhagia and retrograde menstruation increase iron loss. Low ferritin — even without frank anemia — impairs dopamine synthesis, reduces thyroid peroxidase function, and is independently associated with depressive symptoms. Research published in the Journal of Nutrition (Beard et al., 2005; PMID: 15795456) demonstrated that iron repletion in iron-deficient non-anemic women improved mood scores independently of hemoglobin changes. For a detailed breakdown of why iron status drops, see what causes low iron in women.

Magnesium

Chronic pain and HPA activation deplete magnesium rapidly — it is consumed in the cortisol synthesis pathway and excreted at higher rates under stress. Magnesium is a cofactor for over 300 enzymatic reactions including serotonin synthesis and NMDA receptor regulation. Low magnesium is strongly associated with anxiety, depression, and poor sleep quality. A 2017 randomized controlled trial found that 248mg elemental magnesium daily significantly reduced depression and anxiety scores in adults with deficiency over six weeks (Tarleton et al., PLOS ONE 2017; PMID: 28654669).

Omega-3 Fatty Acids

The systemic inflammation of endometriosis is partly driven by an excess of pro-inflammatory arachidonic acid metabolites. Omega-3s — specifically EPA — compete with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, shifting eicosanoid production toward anti-inflammatory prostaglandins. EPA also has direct antidepressant effects: a 2019 meta-analysis found that EPA-dominant formulations (≥60% EPA) produced significant antidepressant effects versus placebo, with effect sizes comparable to some pharmaceutical antidepressants (Mocking et al., Translational Psychiatry 2016; PMID: 26978738).

Low mood in endometriosis rarely has a single nutritional cause — it is typically a stack of insufficiencies compounding each other. The same pattern appears in what causes low mood in endometriosis from a clinical root-cause perspective.

Sleep Disruption as a Mood Amplifier

Pain-interrupted sleep is nearly universal in moderate-to-severe endometriosis. What matters beyond the obvious is that sleep deprivation independently suppresses serotonin and BDNF, elevates inflammatory cytokines, and reduces prefrontal cortex regulation of the amygdala — the brain region responsible for emotional reactivity.

This creates a reinforcing cycle: pain disrupts sleep → sleep loss lowers pain threshold → lower threshold increases perceived pain → further sleep disruption. Each turn of this loop deepens the neurochemical substrate of low mood.

Night-time cortisol elevation — common when pain is worst overnight — also suppresses melatonin, compounding sleep architecture problems and extending the mood impact into the next day.

Gut Microbiome and the Estrobolome

A growing body of research connects endometriosis to gut dysbiosis. The "estrobolome" — the collection of gut bacteria that metabolize and recirculate estrogen — is disrupted in endometriosis, contributing to systemic estrogen excess and unpredictable estrogen fluctuations.

Gut dysbiosis also reduces production of short-chain fatty acids (SCFAs), which support intestinal barrier integrity. Increased intestinal permeability allows lipopolysaccharide (LPS) — bacterial cell wall fragments — to enter systemic circulation, triggering low-grade endotoxemia and neuroinflammation that directly suppresses mood. This gut-brain-hormone axis is an area of active research, with several preliminary studies reporting altered microbial diversity in endometriosis compared to controls.

Thyroid Function and Co-occurring Autoimmunity

Endometriosis is associated with elevated rates of autoimmune thyroid disease (Hashimoto's thyroiditis). Subclinical hypothyroidism — TSH elevated but T4 still in range — is a well-documented cause of low mood, cognitive slowing, fatigue, and emotional blunting. Because thyroid symptoms overlap substantially with the mood effects of endometriosis itself, co-occurring hypothyroidism is frequently missed or attributed to the endometriosis alone.

If low mood is accompanied by cold intolerance, hair thinning, constipation, or unexplained weight changes, thyroid screening is warranted. The interaction between hormonal conditions and thyroid function is explored in depth in what causes low mood in perimenopause with hypothyroidism, which covers the overlapping mechanisms relevant to any hormonal condition.

What This Means for Your Formula

Addressing low mood in endometriosis requires targeting the biological mechanisms — not just supplementing generically. Three ingredients with direct relevance to this condition's mood pathways stand out:

Omega-3 (EPA/DHA): Ones formulas include pharmaceutical-grade EPA/DHA at doses calibrated to your inflammatory load. EPA at doses in the 1–2g range has the strongest evidence for mood support and directly counters endometriosis-associated arachidonic acid excess. This is not a generic fish oil recommendation — it is a clinically dosed anti-inflammatory strategy.

Magnesium Glycinate: The glycinate form provides superior absorption and crosses the blood-brain barrier more efficiently than oxide or citrate. Ones uses magnesium glycinate at doses matched to clinical trial evidence, supporting serotonin synthesis, NMDA receptor regulation, and the cortisol pathways driving HPA dysregulation in chronic pain conditions.

Rhodiola Rosea: For HPA dysregulation and the motivationless, flattened low mood of adrenal exhaustion, Rhodiola rosea (standardized to 3% rosavins, 1% salidroside) has demonstrated efficacy in reducing burnout-associated depressive symptoms in a double-blind RCT (Olsson et al., Planta Medica 2009; PMID: 19016404). Ones includes Rhodiola where the AI identifies the cortisol/fatigue pattern consistent with HPA blunting rather than applying it universally.

Because Ones builds formulas from your actual lab data — including ferritin, inflammatory markers, thyroid panels, and nutrient levels — it can identify which of these mechanisms is most active in your case and prioritize accordingly. A 6 or 9-capsule daily plan is assembled by the AI based on the findings, not selected by you from a menu.

Key Takeaways

• Low mood in endometriosis affects up to 86% of those with the condition and is driven by biological mechanisms — not psychological response alone.
• Chronic systemic inflammation (IL-6, TNF-α) disrupts serotonin synthesis, suppresses hippocampal neurogenesis, and creates neuroinflammation via the gut-brain axis.
• Estrogen dysregulation and progesterone resistance destabilize serotonin and GABA pathways; rapid estrogen fluctuations are particularly disruptive to mood.
• HPA axis exhaustion from chronic pain produces a flattened, motivationless low mood distinct from classic depressive sadness.
• Nutrient depletions — particularly iron, magnesium, and omega-3 EPA — compound mood impairment and are addressable with targeted supplementation at clinical doses.
• Co-occurring thyroid autoimmunity should be screened when mood symptoms include fatigue, cold intolerance, or cognitive slowing, as subclinical hypothyroidism is easily missed alongside endometriosis.

Always consult a qualified healthcare provider before starting a supplement protocol, particularly if you are managing a complex condition like endometriosis alongside hormonal therapy or other medications.